Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Ipsos S.A. Inh.

Start price
Target price
Perf. (%)
€39.95
24.02.22
€42.00
24.02.23
29.41%
16.11.22

Could be worthwhile Investment >10% per year
buy
Maisons du Monde SAS

Start price
Target price
Perf. (%)
€18.95
20.02.22
€21.00
20.03.22
-5.01%
21.03.22

Could be worthwhile Investment >10% per year
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€4.07
15.02.22
€5.00
15.03.22
-25.36%
20.02.22

Could be worthwhile Investment >10% per year
buy
Gaussin S.A.

Start price
Target price
Perf. (%)
€6.09
15.02.22
€12.00
15.02.23
-22.06%
16.10.22

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.24
10.02.22
€3.80
10.02.23
-4.81%
11.02.23

Could be worthwhile Investment >10% per year
buy
Sii

Start price
Target price
Perf. (%)
€43.90
10.02.22
€45.00
10.03.22
-12.53%
11.03.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
05.02.22
€20.00
05.02.23
-57.41%
06.02.23

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
buy
Esker S.A.

Start price
Target price
Perf. (%)
€256.00
02.02.22
€220.00
02.02.23
-38.55%
03.02.23

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€7.06
22.01.22
-
22.01.23
-88.74%
23.09.22

Could be worthwhile Investment >10% per year
buy
A.S.T. Groupe S.A.

Start price
Target price
Perf. (%)
€5.84
18.01.22
€8.00
18.01.23
-52.74%
19.01.23

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€6.78
07.12.21
€10.00
07.12.22
4.13%
22.01.22

Could be worthwhile Investment >10% per year
buy
Prodways Group

Start price
Target price
Perf. (%)
€2.92
01.12.21
€3.20
01.12.22
35.27%
02.12.22

Could be worthwhile Investment >10% per year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
Focus Home Interactive SAS

Start price
Target price
Perf. (%)
€38.95
30.11.21
€50.00
30.11.22
18.49%
01.12.22

Could be worthwhile Investment >10% per year